Xencor to Host Third Quarter 2021 Financial Results Webcast and Conference Call on November 8, 2021

MONROVIA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that it will release third quarter 2021 financial results after the market closes on Monday, November 8, 2021. Xencor management will host a webcast...

Click to view original post